Heterozygous Familial Hypercholesterolemia (HeFH) Overview

Save information for later
Sign Up

Learn About Heterozygous Familial Hypercholesterolemia (HeFH)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Heterozygous Familial Hypercholesterolemia (HeFH) Local Doctors?
Mika Hori
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Nagoya, JP 

Mika Hori practices in Nagoya, Japan. Hori is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). Their top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, High Cholesterol, Defective Apolipoprotein B-100, and Pancreaticoduodenectomy.

Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Osaka, JP 

Mariko Shiba-Harada practices in Osaka, Japan. Ms. Shiba-Harada is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). Her top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, High Cholesterol, and Homozygous Familial Hypercholesterolemia (HoFH).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Elite in Heterozygous Familial Hypercholesterolemia (HeFH)
Johannesburg, GT, ZA 

Frederick Raal practices in Johannesburg, South Africa. Mr. Raal is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, and High Cholesterol.

What are the latest Heterozygous Familial Hypercholesterolemia (HeFH) Clinical Trials?
Open-label, Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol

Summary: VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating ...

Match to trials
Find the right clinical trials for you in under a minute
Get started